The small but significant induction of RBD-specific IgA2 in recovered individuals upon the first dose of mRNA vaccine echoes earlier studies that describe IgA2-expressing memory B cells targeting the S protein of SARS-CoV-2 in a subset of COVID-19 recovered patients (37, 38). Here, PROS1 is linked to COVID-19.